• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926216400
Device Problem Bent (1059)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/06/2018
Event Type  malfunction  
Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the severely tortuous mid right coronary artery.A 4.00 x 16 synergy¿ drug-eluting stent was advanced but had difficulties crossing the lesion.The device was removed and it was noted that the proximal edge of the stent struts was lifted.The procedure was completed with a different device.No patient complications were reported and the patient's status was stable.
 
Manufacturer Narrative
Device evaluated by mfr., eval summary attached, method codes, result codes, conclusion codes updated.  device evaluated by mfr.: stent delivery system was returned for analysis.A visual examination of the stent found that the stent was damage across the entire stent length with most severe damage at the proximal end - proximal stent struts were bunched in distal direction.The stent had moved distally on the balloon, leaving part of the proximal balloon body exposed and covering the distal markerband.The maximum crimped stent outer diameter at the time of manufacture was within maximum crimped stent profile measurement.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.The tip was visually and microscopically examined and no signs of damage were noted.A visual and tactile examination found no kinks or damage along the hypotube shaft.A visual and tactile examination of the outer and the inner lumen and mid-shaft section found no issues with the extrusion shaft.The bi-component bond showed no signs of damage or strain.No other issues were identified during the product analysis.The investigation conclusion is operational context as the product meets the design & manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the severely tortuous mid right coronary artery.A 4.00 x 16 synergy¿ drug-eluting stent was advanced but had difficulties crossing the lesion.The device was removed and it was noted that the proximal edge of the stent struts was lifted.The procedure was completed with a different device.No patient complications were reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7627960
MDR Text Key111986238
Report Number2134265-2018-05816
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 06/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/18/2019
Device Model NumberH7493926216400
Device Catalogue Number39262-1640
Device Lot Number21554424
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/14/2018
Initial Date Manufacturer Received 06/07/2018
Initial Date FDA Received06/21/2018
Supplement Dates Manufacturer Received07/05/2018
Supplement Dates FDA Received07/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-